Underweight infants with PH have a high risk of developing retinopathy of prematurity, a leading cause of childhood blindness ...

Allrock raised $50 million to support the launch of a Phase 2a clinical trial testing PH treatment ROC-101 in people with PAH ...

Tenax said the European Patent Office will grant it a patent protecting the use of levosimendan to treat PH-HFpEF in Europe.

Columnist Anna Jeter, thinking of how students are now going back to school, explains how communication and accommodations ...

Pulmonary endarterectomy surgery may more effectively improve pulmonary circulation and heart function for CTEPH than BPA, a ...

Stanford researchers received a multimillion-dollar grant from the NIH to begin a Phase 2 clinical trial of PAH treatment ...

Columnist Jolie Lizana has discovered that sticky bras can make it easier for women to get help in the case of emergency heart failure.

Phaware is launching a special podcast series to raise awareness of Meth-PAH – when the rare disease is caused by the use of ...

Columnist Jen Cueva writes that, while living with chronic pain, acceptance allows her to adapt and self-advocate.

United Therapeutics and Mannkind Corporation are teaming up to develop a new inhaled therapy for pulmonary hypertension. The two companies worked together to develop Tyvaso DPI, a dry powder ...

Corvista Health’s point-of-care device can detect cases of pulmonary hypertension (PH) that other noninvasive diagnostic tools miss, according to a recent case series. “By enabling physicians to ...